Skip to main content
BHC
NYSE Life Sciences

Bausch Health Q2 Revenue Hits $2.85B, Raises Full-Year Guidance

Tom Rudovsky · Reported by PR Newswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.9
Mkt Cap
$1.748B
52W Low
$4.33
52W High
$8.685
52W Position info
13% above low
Off High info
44% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

BHC is trading near its 52-week low of $4.33 (13% above the low).

Summary

Bausch Health delivered a strong Q2 with consolidated revenue of $2.85 billion, up 13% reported and 11% organic. GAAP EPS jumped to $0.68 from $0.40, and adjusted EPS surged 40% to $1.26. Adjusted EBITDA grew 28% to $1.075 billion. The core business excluding Bausch + Lomb posted its 13th straight quarter of growth, with revenue up 16% and adjusted EBITDA up 28%. Management raised full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted cash flow, signaling confidence in sustained momentum. This follows a Q1 marred by a $1.43 billion goodwill impairment; the Q2 rebound and guidance raise suggest the underlying business is recovering faster than feared. The Salix segment led with 21% growth, driven by Xifaxan. With a market cap near $1.75 billion, these results materially improve the earnings trajectory and could prompt a re-rating.

At the time of this announcement, BHC was trading at $4.90 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $4.33 to $8.69. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

BHC - Latest Insights

BHC
Oct 28, 2026, 6:08 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.56
Real-time Price: $8.21 info
Change: +$0.650 (+9%) info
Market Cap: $3.076B info
BHC
Oct 28, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.25
Real-time Price: $8.21 info
Change: -$0.040 (-0.48%) info
Market Cap: $3.076B info
BHC
Oct 28, 2026, 4:01 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $6.92
Real-time Price: $8.21 info
Change: +$1.29 (+19%) info
Market Cap: $3.076B info
BHC
Jul 29, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.85
Real-time Price: $8.21 info
Change: +$3.37 (+69%) info
Market Cap: $3.076B info
BHC
Apr 29, 2026, 6:12 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.63
Real-time Price: $8.21 info
Change: +$2.58 (+46%) info
Market Cap: $3.076B info